<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37667052</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1529-2916</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature immunology</Title><ISOAbbreviation>Nat Immunol</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).</ArticleTitle><Pagination><StartPage>1616</StartPage><EndPage>1627</EndPage><MedlinePgn>1616-1627</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41590-023-01601-2</ELocationID><Abstract><AbstractText>Millions of people are suffering from Long COVID or post-acute sequelae of COVID-19 (PASC). Several biological factors have emerged as potential drivers of PASC pathology. Some individuals with PASC may not fully clear the coronavirus SARS-CoV-2 after acute infection. Instead, replicating virus and/or viral RNA-potentially capable of being translated to produce viral proteins-persist in tissue as a 'reservoir'. This reservoir could modulate host immune responses or release viral proteins into the circulation. Here we review studies that have identified SARS-CoV-2 RNA/protein or immune responses indicative of a SARS-CoV-2 reservoir in PASC samples. Mechanisms by which a SARS-CoV-2 reservoir may contribute to PASC pathology, including coagulation, microbiome and neuroimmune abnormalities, are delineated. We identify research priorities to guide the further study of a SARS-CoV-2 reservoir in PASC, with the goal that clinical trials of antivirals or other therapeutics with potential to clear a SARS-CoV-2 reservoir are accelerated.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Proal</LastName><ForeName>Amy D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0009-0001-9495-8572</Identifier><AffiliationInfo><Affiliation>PolyBio Research Foundation, Medford, MA, USA. aproal@polybio.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>VanElzakker</LastName><ForeName>Michael B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>PolyBio Research Foundation, Medford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurotherapeutics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aleman</LastName><ForeName>Soo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Dept of Infectious Diseases and Unit of Post-Covid Huddinge, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bach</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>PolyBio Research Foundation, Medford, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nonresident Senior Fellow, Brookings Institution, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boribong</LastName><ForeName>Brittany P</ForeName><Initials>BP</Initials><Identifier Source="ORCID">0000-0003-1297-6337</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buggert</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0633-1719</Identifier><AffiliationInfo><Affiliation>Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Huddinge, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cherry</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3956-6610</Identifier><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Perelman School of Medicine, UPENN, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chertow</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-1675-1728</Identifier><AffiliationInfo><Affiliation>Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Helen E</ForeName><Initials>HE</Initials><Identifier Source="ORCID">0000-0001-6102-256X</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospital Llandough, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dupont</LastName><ForeName>Christopher L</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0002-0896-6542</Identifier><AffiliationInfo><Affiliation>J. Craig Venter Institute, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deeks</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eimer</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Disease, Charlestown, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ely</LastName><ForeName>E Wesley</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>The Critical Illness, Brain Dysfunction, Survivorship (CIBS) Center at Vanderbilt University Medical Center and the Veteran's Affairs Tennessee Valley Geriatric Research Education Clinical Center (GRECC), Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fasano</LastName><ForeName>Alessio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freire</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4906-7698</Identifier><AffiliationInfo><Affiliation>J. Craig Venter Institute Department of Infectious Diseases, University of California, San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Linda N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffin</LastName><ForeName>Diane E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henrich</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Division of Experimental Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwasaki</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7824-9856</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale University School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Chevy Chase, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izquierdo-Garcia</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology, Harvard Medical School, Charlestown, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Locci</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Immunology and Immune Health, and Department of Microbiology, University of Pennsylvania Perelman School Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehandru</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9781-2969</Identifier><AffiliationInfo><Affiliation>Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Painter</LastName><ForeName>Mark M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-0180-2748</Identifier><AffiliationInfo><Affiliation>Institute for Immunology and Immune Health, and Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peluso</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Etheresia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>David A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0001-9416-2737</Identifier><AffiliationInfo><Affiliation>Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Systems Immunity Research Institute, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putrino</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheuermann</LastName><ForeName>Richard H</ForeName><Initials>RH</Initials><Identifier Source="ORCID">0000-0003-1355-892X</Identifier><AffiliationInfo><Affiliation>Department of Informatics, J. Craig Venter Institute, La Jolla, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, University of California, San Diego, San Diego, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>La Jolla Institute for Immunology, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Gene S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>J. Craig Venter Institute, La Jolla, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Medicine, University of California San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanzi</LastName><ForeName>Rudolph E</ForeName><Initials>RE</Initials><Identifier Source="ORCID">0000-0002-7032-1454</Identifier><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Disease, Charlestown, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>VanBrocklin</LastName><ForeName>Henry F</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yonker</LastName><ForeName>Lael M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0003-1711-8227</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wherry</LastName><ForeName>E John</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0003-0477-1956</Identifier><AffiliationInfo><Affiliation>Institute for Immunology and Immune Health, and Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School Medicine, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 HL143183</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI157875</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI147159</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Immunol</MedlineTA><NlmUniqueID>100941354</NlmUniqueID><ISSNLinking>1529-2908</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Immunol. 2023 Oct;24(10):1778. doi: 10.1038/s41590-023-01646-3</RefSource><PMID Version="1">37723351</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37667052</ArticleId><ArticleId IdType="doi">10.1038/s41590-023-01601-2</ArticleId><ArticleId IdType="pii">10.1038/s41590-023-01601-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proal, A. D. &amp; VanElzakker, M. B. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. https://doi.org/10.3389/FMICB.2021.698169 (2021).</Citation></Reference><Reference><Citation>National Center for Health Statistics. US Census Bureau, Household Pulse Survey, 2022&#x2013;2023. Long COVID (2023).</Citation></Reference><Reference><Citation>Cutler, D. M. The economic cost of long COVID: an update (2023). White Paper. https://scholar.harvard.edu/files/cutler/files/long_covid_update_7-22.pdf (2023).</Citation></Reference><Reference><Citation>Davis, H. E., McCorkell, L., Vogel, J. M. &amp; Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. https://doi.org/10.1038/S41579-022-00846-2 (2023).</Citation></Reference><Reference><Citation>Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine https://doi.org/10.1016/J.ECLINM.2021.101019 (2021).</Citation></Reference><Reference><Citation>Petersen, E. L. et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme. Eur. Heart J. 43, 1124&#x2013;1137 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34999762</ArticleId><ArticleId IdType="pmc">8755397</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso, M. J. et al. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement. Open Forum Infect. Dis. https://doi.org/10.1093/OFID/OFAB640 (2022).</Citation></Reference><Reference><Citation>Lopez-Leon, S. et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci. Rep. https://doi.org/10.1038/S41598-022-13495-5 (2022).</Citation></Reference><Reference><Citation>Funk, A. L. et al. Post&#x2013;COVID-19 conditions among children 90 days after SARS-CoV-2 infection. JAMA Netw. Open. 5, E2223253 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35867061</ArticleId><ArticleId IdType="pmc">9308058</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Health department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States. https://www.cdc.gov/mis/index.html (2023).</Citation></Reference><Reference><Citation>Keita, A. K. et al. A 40-month follow-up of Ebola virus disease survivors in Guinea (Postebogui) reveals long-term detection of Ebola viral ribonucleic acid in semen and breast milk. Open Forum Infect. Dis. https://doi.org/10.1093/ofid/ofz482 (2019).</Citation></Reference><Reference><Citation>Varkey, J. B. et al. Persistence of Ebola virus in ocular fluid during convalescence. N. Engl. J. Med. 372, 2423&#x2013;2427 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25950269</ArticleId><ArticleId IdType="pmc">4547451</ArticleId></ArticleIdList></Reference><Reference><Citation>Sow, M. S. et al. New evidence of long-lasting persistence of Ebola virus genetic material in semen of survivors. J. Infect. Dis. 214, 1475&#x2013;1476 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27142204</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz-Bailey, G. et al. Persistence of Zika virus in body fluids&#x2014;final report. N. Engl. J. Med. 379, 1234&#x2013;1243 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28195756</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia, J. K. S. &amp; Chia, A. Y. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J. Clin. Pathol. 61, 43&#x2013;48 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">17872383</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hl, U. et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112, 1965&#x2013;1970 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16172268</ArticleId></ArticleIdList></Reference><Reference><Citation>Permar, S. R. et al. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J. Infect. Dis. 183, 532&#x2013;538 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11170977</ArticleId></ArticleIdList></Reference><Reference><Citation>Riddell, M. A., Moss, W. J., Hauer, D., Monze, M. &amp; Griffin, D. E. Slow clearance of measles virus RNA after acute infection. J. Clin. Virol. 39, 312&#x2013;317 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17625962</ArticleId></ArticleIdList></Reference><Reference><Citation>Dokubo, E. K. et al. Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report. Lancet Infect. Dis. 18, 1015&#x2013;1024 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30049622</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott, J. T. et al. Post-Ebola syndrome, Sierra Leone. Emerg. Infect. Dis. 22, 641&#x2013;646 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26983037</ArticleId><ArticleId IdType="pmc">4806950</ArticleId></ArticleIdList></Reference><Reference><Citation>Subissi, L. et al. Ebola virus transmission caused by persistently infected survivors of the 2014-2016 outbreak in West Africa. J. Infect. Dis. 218, S287&#x2013;S291 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29920602</ArticleId><ArticleId IdType="pmc">6249578</ArticleId></ArticleIdList></Reference><Reference><Citation>Keita, A. K. et al. Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks. Nature 597, 539&#x2013;543 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34526718</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell, K. et al. Male-to-Female sexual transmission of Zika virus&#x2014;United States, January&#x2013;April 2016. Clin. Infect. Dis. 64, 211&#x2013;213 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27986688</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso, M. J. et al. Multimodal molecular imaging reveals tissue-based T cell activation and viral RNA persistence for up to 2 years following COVID-19. Preprint at medRxiv https://doi.org/10.1101/2023.07.27.23293177 (2023).</Citation></Reference><Reference><Citation>Yao, Q. et al. Long-term dysfunction of taste papillae in SARS-CoV-2. NEJM Evidence. https://doi.org/10.1056/EVIDoa2300046 (2023).</Citation></Reference><Reference><Citation>Rendeiro, A. F. et al. Persistent alveolar type 2 dysfunction and lung structural derangement in post-acute COVID-19. Preprint at medRxiv https://doi.org/10.1101/2022.11.28.22282811 (2022).</Citation></Reference><Reference><Citation>de Melo, G. D. et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. https://doi.org/10.1126/SCITRANSLMED.ABF8396 (2021).</Citation></Reference><Reference><Citation>Cheung, C. C. L. et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut https://doi.org/10.1136/gutjnl-2021-324280 (2021).</Citation></Reference><Reference><Citation>Hany, M. et al. Lingering SARS-CoV-2 in gastric and gallbladder tissues of patients with previous COVID-19 infection undergoing bariatric surgery. Obes. Surg. 33, 139&#x2013;148 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36316598</ArticleId><ArticleId IdType="pmc">9628579</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura, C. S. et al. Asymptomatic SARS-COV-2 infection in children&#x2019;s tonsils. Braz. J. Otorhinolaryngol. 88, 9 (2022).</Citation></Reference><Reference><Citation>Stein, S. R. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758&#x2013;763 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36517603</ArticleId><ArticleId IdType="pmc">9749650</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden, A. C. et al. Late complications of COVID-19: a morphologic, imaging, and droplet digital polymerase chain reaction study of lung tissue. Arch. Pathol. Lab. Med. https://doi.org/10.5858/arpa.2021-0519-sa (2022).</Citation></Reference><Reference><Citation>Gaebler, C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639&#x2013;644 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33461210</ArticleId><ArticleId IdType="pmc">8221082</ArticleId></ArticleIdList></Reference><Reference><Citation>Aid, M. et al. Zika virus persistence in the central nervous system and lymph nodes of rhesus monkeys. Cell 169, 610&#x2013;620 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28457610</ArticleId><ArticleId IdType="pmc">5426912</ArticleId></ArticleIdList></Reference><Reference><Citation>Mead, P. S. et al. Zika virus shedding in semen of symptomatic infected men. N. Engl. J. Med. 378, 1377&#x2013;1385 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29641964</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffin, K. M. et al. Persistent Marburg virus infection in the testes of nonhuman primate survivors. Cell Host Microbe 24, 405&#x2013;416 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30173956</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, Q. et al. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children. Nat. Immunol. 24, 186&#x2013;199 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36536106</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner, A. et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology 163, 495&#x2013;506 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh, D. et al. Case report: persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Front Immunol. 13, 939989 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36131932</ArticleId><ArticleId IdType="pmc">9483160</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf;, C. et al. Liquid biomarkers of macrophage dysregulation and circulating spike protein 1 illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. J. Med. Virol. https://doi.org/10.1002/jmv.28364 (2023).</Citation></Reference><Reference><Citation>Swank, Z. et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin. Infect. Dis. https://doi.org/10.1093/CID/CIAC722 (2022).</Citation></Reference><Reference><Citation>Peluso, M. et al. Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection. Poster presentation. https://www.croiconference.org/abstract/plasma-based-antigen-persistence-in-the-post-acute-phase-of-sars-cov-2-infection/ (2023).</Citation></Reference><Reference><Citation>Ogata, A. F. et al. Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients. Clin. Infect. Dis. 74, 715&#x2013;718 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34015087</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso, M. J. et al. SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann. Neurol. 91, 772&#x2013;781 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35285072</ArticleId><ArticleId IdType="pmc">9082480</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock, V. et al. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J. Med. Virol. https://doi.org/10.1002/JMV.28568 (2023).</Citation></Reference><Reference><Citation>Adaken, C. et al. Ebola virus antibody decay&#x2013;stimulation in a high proportion of survivors. Nature 590, 468&#x2013;472 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33505020</ArticleId><ArticleId IdType="pmc">7839293</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson, A. N. et al. Evolution of T cell responses during measles virus infection and RNA clearance. Sci. Rep. 7, 11474 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28904342</ArticleId><ArticleId IdType="pmc">5597584</ArticleId></ArticleIdList></Reference><Reference><Citation>Herati, R. S. et al. PD-1 directed immunotherapy alters T<sub>fh</sub> and humoral immune responses to seasonal influenza vaccine. Nat. Immunol. 23, 1183&#x2013;1192 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35902637</ArticleId><ArticleId IdType="pmc">9880663</ArticleId></ArticleIdList></Reference><Reference><Citation>Herati, R. S. et al. Vaccine-induced ICOS<sup>+</sup>CD38<sup>+</sup> circulating T<sub>fh</sub> are sensitive biosensors of age-related changes in inflammatory pathways. Cell Rep. Med. https://doi.org/10.1016/J.XCRM.2021.100262 (2021).</Citation></Reference><Reference><Citation>Sykulev, Y., Joo, M., Vturina, I., Tsomides, T. J. &amp; Eisen, H. N. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4, 565&#x2013;571 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R. &amp; Ahmed, R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911&#x2013;4927 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12663797</ArticleId><ArticleId IdType="pmc">152117</ArticleId></ArticleIdList></Reference><Reference><Citation>Appay, V. et al. Memory CD8<sup>+</sup> T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8, 379&#x2013;385 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11927944</ArticleId></ArticleIdList></Reference><Reference><Citation>Purbhoo, M. A., Irvine, D. J., Huppa, J. B. &amp; Davis, M. M. T cell killing does not require the formation of a stable mature immunological synapse. Nat. Immunol. 5, 524&#x2013;530 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15048111</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibholm, L. K. et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine https://doi.org/10.1016/j.ebiom.2021.103230 (2021).</Citation></Reference><Reference><Citation>Peluso, M. J. et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. https://doi.org/10.1016/J.CELREP.2021.109518 (2021).</Citation></Reference><Reference><Citation>Littlefield, K. M. et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 18, e1010359 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35617421</ArticleId><ArticleId IdType="pmc">9176759</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy, L. et al. T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID. Preprint at medRxiv https://doi.org/10.1101/2021.08.08.21261763 (2022).</Citation></Reference><Reference><Citation>Yin, K. et al. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. Preprint at bioRxiv https://doi.org/10.1101/2023.02.09.527892 (2023).</Citation></Reference><Reference><Citation>Klein, J. et al. Distinguishing features of Long COVID identified through immune profiling. Preprint at medRxiv https://doi.org/10.1101/2022.08.09.22278592 (2022).</Citation></Reference><Reference><Citation>Santa Cruz, A. et al. Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8<sup>+</sup> &#x3b2;7 integrin<sup>+</sup> T cells and anti-SARS-CoV-2 IgA response. Nat. Commun. 14, 1772 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36997530</ArticleId><ArticleId IdType="pmc">10061413</ArticleId></ArticleIdList></Reference><Reference><Citation>Metcalf, T. U. &amp; Griffin, D. E. Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system. J. Virol. 85, 11490&#x2013;11501 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21865385</ArticleId><ArticleId IdType="pmc">3194963</ArticleId></ArticleIdList></Reference><Reference><Citation>Metcalf, T. U., Baxter, V. K., Nilaratanakul, V. &amp; Griffin, D. E. Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis. J. Virol. 87, 2420&#x2013;2429 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23255791</ArticleId><ArticleId IdType="pmc">3571404</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson, A. N. et al. Association of persistent wild-type measles virus RNA with long-term humoral immunity in rhesus macaques. JCI Insight https://doi.org/10.1172/JCI.INSIGHT.134992 (2020).</Citation></Reference><Reference><Citation>Yewdell, W. T. et al. Temporal dynamics of persistent germinal centers and memory B cell differentiation following respiratory virus infection. Cell Rep. 37, 109961 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34758310</ArticleId><ArticleId IdType="pmc">7612942</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, T. S., Hufford, M. M., Sun, J., Fu, Y. X. &amp; Braciale, T. J. Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J. Exp. Med. 207, 1161&#x2013;1172 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20513748</ArticleId><ArticleId IdType="pmc">2882836</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho, R. V. H. et al. Clonal replacement sustains long-lived germinal centers primed by respiratory viruses. Cell 186, 131&#x2013;146 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36565697</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid, F. et al. Roles and functions of SARS-CoV-2 proteins in host immune evasion. Front. Immunol. https://doi.org/10.3389/FIMMU.2022.940756 (2022).</Citation></Reference><Reference><Citation>Kee, J. et al. SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. Nature 610, 381&#x2013;388 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36198800</ArticleId><ArticleId IdType="pmc">9533993</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E. et al. Persistent clotting protein pathology in Long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. https://doi.org/10.1186/s12933-021-01359-7 (2021).</Citation></Reference><Reference><Citation>Grobbelaar, L. M. et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci. Rep. https://doi.org/10.1042/BSR20210611 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId><ArticleId IdType="pmc">8380922</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu, J. K. et al. SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy. Preprint at bioRxiv https://doi.org/10.1101/2021.10.12.464152 (2021).</Citation></Reference><Reference><Citation>De Michele, M. et al. Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients. J. Hematol. Oncol. 15, 108 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35974404</ArticleId><ArticleId IdType="pmc">9380658</ArticleId></ArticleIdList></Reference><Reference><Citation>Boribong, B. P. et al. Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children. Cell Rep. Med. https://doi.org/10.1016/J.XCRM.2022.100848 (2022).</Citation></Reference><Reference><Citation>Cervia, C. et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. https://doi.org/10.1038/S41467-021-27797-1 (2022).</Citation></Reference><Reference><Citation>Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718&#x2013;724 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32661059</ArticleId><ArticleId IdType="pmc">7402632</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold, J. E., Okyay, R. A., Licht, W. E. &amp; Hurley, D. J. Investigation of long COVID prevalence and its relationship to Epstein&#x2013;Barr virus reactivation. Pathogens https://doi.org/10.3390/PATHOGENS10060763 (2021).</Citation></Reference><Reference><Citation>Peluso, M. J. et al. Impact of pre-existing chronic viral infection and reactivation on the development of long COVID. J. Clin. Invest. https://doi.org/10.1172/JCI163669 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell https://doi.org/10.1016/j.cell.2022.01.014 (2022).</Citation></Reference><Reference><Citation>Gu, L. et al. Dynamic changes in the microbiome and mucosal immune microenvironment of the lower respiratory tract by influenza virus infection. Front Microbiol. https://doi.org/10.3389/FMICB.2019.02491 (2019).</Citation></Reference><Reference><Citation>Kaul, D. et al. Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection. Nat Commun. https://doi.org/10.1038/s41467-020-16429-9 (2020).</Citation></Reference><Reference><Citation>Eastment, M. C. &amp; McClelland, R. S. Vaginal microbiota and susceptibility to HIV. AIDS 32, 687&#x2013;698 (2018).</Citation></Reference><Reference><Citation>Liu, Q. et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 71, 544&#x2013;552 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron, L. B. et al. Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-&#x3ba;B signaling. JCI Insight https://doi.org/10.1172/JCI.INSIGHT.160989 (2022).</Citation></Reference><Reference><Citation>Yonker, L. M. et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J. Clin. Invest. https://doi.org/10.1172/JCI149633 (2021).</Citation></Reference><Reference><Citation>Wang, W., Uzzau, S., Goldblum, S. E. &amp; Fasano, A. Human zonulin, a potential modulator of intestinal tight junctions. J. Cell Sci. https://doi.org/10.1242/jcs.113.24.4435 (2000).</Citation></Reference><Reference><Citation>Fasano, A. et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet https://doi.org/10.1016/S0140-6736(00)02169-3 (2000).</Citation></Reference><Reference><Citation>Malik, A. et al. Distorted TCR repertoires define multisystem inflammatory syndrome in children. PLoS ONE 17, e0274289 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36301874</ArticleId><ArticleId IdType="pmc">9612519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreye, J., Reincke, S. M. &amp; Pr&#xfc;ss, H. Do cross-reactive antibodies cause neuropathology in COVID-19. Nat. Rev. Immunol. 20, 645&#x2013;646 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33024283</ArticleId><ArticleId IdType="pmc">7537977</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321&#x2013;327 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35073561</ArticleId><ArticleId IdType="pmc">9382663</ArticleId></ArticleIdList></Reference><Reference><Citation>McCusker, R. H. &amp; Kelley, K. W. Immune&#x2013;neural connections: how the immune system&#x2019;s response to infectious agents influences behavior. J. Exp. Biol. 216, 84&#x2013;98 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23225871</ArticleId><ArticleId IdType="pmc">3515033</ArticleId></ArticleIdList></Reference><Reference><Citation>Goehler, L. E. et al. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav. Immun. 19, 334&#x2013;344 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15944073</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker, M. B. Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis. Med. Hypotheses 81, 414&#x2013;423 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23790471</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo, M. S. et al. Vagus nerve inflammation contributes to dysautonomia in COVID-19. Acta Neuropathol. 146, 387&#x2013;394 (2023).</Citation></Reference><Reference><Citation>Matschke, J. et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 19, 919&#x2013;929 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33031735</ArticleId><ArticleId IdType="pmc">7535629</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, E. et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. https://doi.org/10.1084/JEM.20202135 (2021).</Citation></Reference><Reference><Citation>Wang, L. et al. Association of COVID-19 with new-onset Alzheimer&#x2019;s disease. J. Alzheimers Dis. 89, 411&#x2013;414 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35912749</ArticleId><ArticleId IdType="pmc">10361652</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes, C. H., Priemer, D. S., Karlovich, E., Perl, D. P. &amp; Goldman, J. &#x3b2;-amyloid deposits in young COVID patients. SSRN Electronic Journal https://doi.org/10.2139/SSRN.4003213 (2022).</Citation></Reference><Reference><Citation>Soscia, S. J. et al. The Alzheimer&#x2019;s disease-associated amyloid &#x3b2;-protein is an antimicrobial peptide. PLoS ONE https://doi.org/10.1371/JOURNAL.PONE.0009505 (2010).</Citation></Reference><Reference><Citation>Eimer, W. A. et al. Alzheimer&#x2019;s disease-associated &#x3b2;-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99, 56&#x2013;63 (2018).</Citation></Reference><Reference><Citation>Kumar, D. K. V. et al. Amyloid-&#x3b2; peptide protects against microbial infection in mouse and worm models of Alzheimer&#x2019;s disease. Sci. Transl. Med. 8, 340ra72 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27225182</ArticleId></ArticleIdList></Reference><Reference><Citation>Aung, A. et al. Low protease activity in B cell follicles promotes retention of intact antigens after immunization. Science https://doi.org/10.1126/SCIENCE.ABN8934/SUPPL_FILE/SCIENCE.ABN8934_MDAR_REPRODUCIBILITY_CHECKLIST.PDF (2023).</Citation></Reference><Reference><Citation>Griffin, D. E. Why does viral RNA sometimes persist after recovery from acute infections? PLoS Biol. 20, e3001687 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35648781</ArticleId><ArticleId IdType="pmc">9191737</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmler, L. et al. Feline coronavirus with and without spike gene mutations detected by real-time RT&#x2013;PCRs in cats with feline infectious peritonitis. J. Feline Med. Surg. 22, 791&#x2013;799 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31729897</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad, N. et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression. Proc. Natl Acad. Sci. 120, e2208525120120 (2023).</Citation></Reference><Reference><Citation>Moriyama, M., Lucas, C., Monteiro, V. S., Yale SARS-CoV-2 Genomic Surveillance Initiative &amp; Iwasaki, A. SARS-CoV-2 Omicron subvariants evolved to promote further escape from MHC-I recognition. Preprint at bioRxiv https://doi.org/10.1101/2022.05.04.490614 (2022).</Citation></Reference><Reference><Citation>Peluso, M. J. et al. Effect of oral nirmatrelvir on Long COVID symptoms: a case series. https://doi.org/10.21203/RS.3.RS-1617822/V2 (2022).</Citation></Reference><Reference><Citation>Geng, L. N., Bonilla, H. F., Shafer, R. W., Miglis, M. G., Yang, P. C. Case report of breakthrough long COVID and the use of nirmatrelvir-ritonavir. Preprint at Research Square https://doi.org/10.21203/rs.3.rs-1443341/v1 (2022).</Citation></Reference><Reference><Citation>Schultz, D. C. et al. Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2. Nature 604, 134&#x2013;140 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35130559</ArticleId><ArticleId IdType="pmc">10377386</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Choi, T. &amp; Al-Aly Z. Nirmatrelvir and the risk of post-acute sequelae of COVID-19. Preprint at medRxiv https://doi.org/10.1101/2022.11.03.22281783 (2022).</Citation></Reference><Reference><Citation>Yonker, L. M. et al. Zonulin antagonist, Larazotide (AT1001), as an adjuvant treatment for multisystem inflammatory syndrome in children: a case series. Crit. Care Explor. 4, e0641 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">8860335</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal, A. &amp; Marshall, T. Myalgic encephalomyelitis/chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity. Front. Pediatr. https://doi.org/10.3389/fped.2018.00373 (2018).</Citation></Reference><Reference><Citation>Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein&#x2013;Barr virus associated with multiple sclerosis. Science 375, 296&#x2013;301 (2022).</Citation></Reference><Reference><Citation>Harley, J. B. et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat. Genet. 50, 699&#x2013;707 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29662164</ArticleId><ArticleId IdType="pmc">6022759</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung, C. C. L. et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut 71, 226&#x2013;229 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan, A. et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 3, 371&#x2013;387 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, J. C. et al. SARS-CoV-2 detected in neonatal stool remote from maternal COVID-19 during pregnancy. Pediatr. Res. https://doi.org/10.1038/s41390-022-02266-7 (2022).</Citation></Reference><Reference><Citation>Tejerina, F. et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 22, 211 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35240997</ArticleId><ArticleId IdType="pmc">8892394</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>